Fluticasone Propionate

CAS 80474-14-2 27 current records 3 historicalSmall Molecule

Who holds supplier records for Fluticasone Propionate? 27 organisations hold a current record for Fluticasone Propionate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 19 of them hold a valid EU Certificate of Suitability (20 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (6), China (4), Italy (4), Israel (2) and 7 other countries (7); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Fluticasone Propionate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fluticasone-propionate

Reading the evidence

  • 27 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 16 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Fluticasone Propionate expires 23 Feb 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (27)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Fluticasone Propionate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Cipla Limited
    Active DMF 30417, 15774, 33172 · latest filing Nov 2018
    IndiaCEP Company GMP cert on record
  • Aurisco Pharmaceutical Co.,ltd
    Active DMF 34273, 20212 · latest filing Nov 2019
    ChinaCEP Company GMP cert on record
  • CORAL DRUGS PVT LTD
    Active DMF 21879, 36315 · latest filing Nov 2021
    IndiaCEP Company GMP cert on record
  • GLAXOSMITHKLINE LLCAlso filed as GLAXOSMITHKLINE
    Active DMF 32952, 31534 · latest filing Aug 2018
  • AARTI PHARMALABS LIMITED
    Active DMF 22980 · latest filing Jul 2009
    IndiaCEP
  • BREATHGREEN PHARMACEUTICAL CO LTD
    Active DMF 38759 · latest filing Aug 2023
    CEP
  • CURIA SPAIN SAU
    Active DMF 37297 · latest filing Sept 2022
    SpainCEP Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 20463 · latest filing Apr 2007
    ItalyCEP Company GMP cert on record
  • Hovione FarmaCiencia SA
    Active DMF 16334 · latest filing Dec 2002
    PortugalCEP Company GMP cert on record
  • INDUSTRIALE CHIMICA SRL
    Active DMF 23427 · latest filing Jan 2010
    ItalyCEP Company GMP cert on record
  • NEWCHEM SPA
    Active DMF 22236 · latest filing Nov 2008
    ItalyCEP Company GMP cert on record
  • SHANDONG SIRUI PHARMACEUTICAL CO LTD
    Active DMF 35359 · latest filing Mar 2021
    CEP
  • STERLING SPA
    Active DMF 16423 · latest filing Feb 2003
    ItalyCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 15745 · latest filing Nov 2001
    NetherlandsCEP
  • VAMSI LABS LTD
    Active DMF 40285, 42812 · latest filing Nov 2025
    IndiaCEP Company GMP cert on record
  • WAVELENGTH ENTERPRISES LTD
    Active DMF 15456 · latest filing May 2001
    IsraelCEP Company GMP cert on record
  • Amphastar Nanjing Pharmaceuticals
    Active DMF 29454 · latest filing Jun 2015
    China
  • Apotex Inc.
    Active DMF 35393 · latest filing Dec 2020
    Canada
  • Hubei Gedian Humanwell Pharmaceutical Co. Ltd
    Active DMF 44220 · latest filing May 2026
    China Company GMP cert on record
  • Lupin Limited
    Active DMF 29975 · latest filing Dec 2015
    India Company GMP cert on record
  • SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD
    Active DMF 44395 · latest filing Jun 2026
  • Taro Pharmaceutical Industries Ltd.
    Active DMF 17618 · latest filing Aug 2004
    Israel Company GMP cert on record
  • TIANJIN TIANYAO PHARMACEUTICALS CO LTD
    Active DMF 34126 · latest filing Dec 2019
    China
  • FinlandCEP Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Inactive DMF 17544 · latest filing Jul 2004
    IndiaCEP Company GMP cert on record
  • GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    United KingdomCEP
  • EUROAPI FRANCE Vertolaye
    Valid CEP holder (EDQM); not necessarily the manufacturer
    FranceCEP
Need Fluticasone Propionate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (20)

Certificates of Suitability on the EDQM register for Fluticasone Propionate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 33 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TAPI NL B.V. AmsterdamNL
CEP 2026-230 - Rev 00
Fluticasone propionate, Sicor Italy- 6706MO
Aug 2026—
CIPLA LIMITED MumbaiIN
CEP 2020-075 - Rev 03
Fluticasone propionate, Modified Process II, Micronised
Jul 2026—
FERMION OY EspooFI
CEP 2020-008 - Rev 03
Fluticasone propionate, Micronised, non-micronised
Jun 2026Inspected Feb 2026
Finland
NEWCHEM S.p.A. MilanIT
CEP 2006-093 - Rev 06
Fluticasone propionate, Micronised, non-micronised
Jun 2026—
HOVIONE FARMACIENCIA S.A. LouresPT
CEP 2005-160 - Rev 03
Fluticasone propionate, Micronised
Dec 2025Inspected Apr 2025
Portugal
VAMSI LABS LIMITED SolapurIN
CEP 2020-078 - Rev 03
Fluticasone propionate, Micronised
Jun 2025—
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED LondonGB
CEP 2018-229 - Rev 03
Fluticasone propionate, Micronised
Apr 2025—
CURIA SPAIN S.A.U. BoecilloES
CEP 2013-315 - Rev 02
Fluticasone propionate
Feb 2025Inspected Feb 2026
Spain
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2007-192 - Rev 09
Fluticasone propionate
Nov 2024—
BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang CityCN
CEP 2023-292 - Rev 00
Fluticasone propionate, Micronised
Jul 2024—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2008-117 - Rev 02
Fluticasone propionate, Micronised
May 2024Inspected Jul 2026
Italy
SHANDONG SIRUI PHARMACEUTICAL CO., LTD. HezeCN
CEP 2022-282 - Rev 00
Fluticasone propionate
May 2024—
AURISCO PHARMACEUTICAL CO., LTD. TiantaiCN
CEP 2023-360 - Rev 00
Fluticasone propionate, Process FCPB
Mar 2024Inspected Dec 2023
Germany
CORAL DRUGS PRIVATE LIMITED New DelhiIN
R0-CEP 2021-492 - Rev 00
Fluticasone propionate, Process 1
Jun 2023—
EUROAPI FRANCE VertolayeFR
R1-CEP 2018-040 - Rev 00
Fluticasone propionate, Non-micronised, micronised
May 2023—
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
R1-CEP 2007-262 - Rev 03
Fluticasone propionate
Oct 2022—
CIPLA LIMITED MumbaiIN
R1-CEP 2012-001 - Rev 02
Fluticasone propionate, Process II, micronised, grades I and II
Mar 2022—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2004-231 - Rev 04
Fluticasone propionate
Dec 2019—
INDUSTRIALE CHIMICA S.R.L. SaronnoIT
R1-CEP 2012-024 - Rev 00
Fluticasone propionate
Feb 2019—
STERLING S.p.A. Solomeo Di CorcianoIT
R1-CEP 2005-268 - Rev 02
Fluticasone propionate
Feb 2016—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Fluticasone Propionate are no longer active. These show a past filing, not current supply.

Show all 3 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Fluticasone Propionate). The latest listed patent expires 23 Feb 2036. The latest listed exclusivity runs to 15 Mar 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Fluticasone Propionate is a synthetic glucocorticoid with anti-inflammatory and vasoconstrictive properties. It is commonly used in the treatment of respiratory disorders such as asthma and allergic rhinitis.

Chemical identity

IUPAC name
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Canonical SMILES
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF
InChIKey
WMWTYOKRWGGJOA-CENSZEJFSA-N
Synonyms
Flonase API, advair component fluticasone propionate, armonair respiclick, cci-18781, cci18781, cutivate, dymista component fluticasone propionate, flixotide, flonase, flovent, fluticasone-17-propionate, nsc-759889

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

RespiratoryAllergyDermatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Fluticasone Propionate?

27 organisations hold an active US FDA Type II Drug Master File or a CEP for Fluticasone Propionate: Cipla Limited (India), Aurisco Pharmaceutical Co.,ltd (China), CORAL DRUGS PVT LTD (India), GLAXOSMITHKLINE LLC, AARTI PHARMALABS LIMITED (India), BREATHGREEN PHARMACEUTICAL CO LTD, CURIA SPAIN SAU (Spain) and Farmabios S.p.A. (Italy), and 19 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Fluticasone Propionate Drug Master Files are active?

Cipla Limited (DMF 30417, 15774), Aurisco Pharmaceutical Co.,ltd (DMF 34273, 20212), CORAL DRUGS PVT LTD (DMF 21879, 36315), GLAXOSMITHKLINE LLC (DMF 32952, 31534), AARTI PHARMALABS LIMITED (DMF 22980), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 38759), CURIA SPAIN SAU (DMF 37297) and Farmabios S.p.A. (DMF 20463) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Fluticasone Propionate records mean?

3 organisations have only inactive Type II DMFs for Fluticasone Propionate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Fluticasone Propionate have a European Certificate of Suitability?

Yes. 19 organisations hold a valid CEP for Fluticasone Propionate on the EDQM register, including TAPI NL B.V. Amsterdam (NL), CIPLA LIMITED Mumbai (IN), FERMION OY Espoo (FI), NEWCHEM S.p.A. Milan (IT), HOVIONE FARMACIENCIA S.A. Loures (PT) and VAMSI LABS LIMITED Solapur (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Fluticasone Propionate?

Yes. The latest patent listed for an approved US product containing Fluticasone Propionate expires 23 Feb 2036, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Fluticasone Propionate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Fluticasone Propionate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.